STERIS plc (NYSE: STE) Stock Competitors & Peer Comparison
See STE's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for STE and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| STE | $233.85 | -1.16% | 23B | 22.65 | $10.42 | +1.07% |
| ALC | $74.58 | +1.36% | 35.8B | 23.11 | $3.18 | +0.49% |
| BRKRP | $425.66 | -2.82% | 8.6B | 234.03 | $1.84 | +0.34% |
| DRTSW | $3.79 | +6.16% | 1.5B | -6.02 | -$0.65 | N/A |
| MASS | $10.19 | +1.70% | 414.8M | -16.85 | -$0.60 | N/A |
| SI | $19.31 | -0.16% | 398.8M | -10.04 | -$1.91 | N/A |
| MOBI | $11.55 | +0.26% | 388.3M | -0.62 | -$18.78 | N/A |
| EDAP | $4.76 | -0.52% | 178.2M | -5.80 | -$0.82 | N/A |
| NYXH | $1.57 | -0.63% | 158.1M | -0.63 | -$2.52 | N/A |
| APYX | $3.10 | +3.79% | 128M | -13.82 | -$0.22 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
STE vs ALC Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, ALC has a market cap of 35.8B. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while ALC trades at $74.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas ALC's P/E ratio is 23.11. In terms of profitability, STE's ROE is +0.11%, compared to ALC's ROE of +0.03%. Regarding short-term risk, STE is less volatile compared to ALC. This indicates lower risk in terms of short-term price fluctuations for STE.Check ALC's competition here
Bruker Corporation (NASDAQ: BRKRP)
STE vs BRKRP Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, BRKRP has a market cap of 8.6B. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while BRKRP trades at $425.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas BRKRP's P/E ratio is 234.03. In terms of profitability, STE's ROE is +0.11%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, STE is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for STE.Check BRKRP's competition here
Alpha Tau Medical Ltd. (NASDAQ: DRTSW)
STE vs DRTSW Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, DRTSW has a market cap of 1.5B. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while DRTSW trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas DRTSW's P/E ratio is -6.02. In terms of profitability, STE's ROE is +0.11%, compared to DRTSW's ROE of -1.38%. Regarding short-term risk, STE is less volatile compared to DRTSW. This indicates lower risk in terms of short-term price fluctuations for STE.Check DRTSW's competition here
908 Devices Inc. (NASDAQ: MASS)
STE vs MASS Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, MASS has a market cap of 414.8M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while MASS trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas MASS's P/E ratio is -16.85. In terms of profitability, STE's ROE is +0.11%, compared to MASS's ROE of -0.25%. Regarding short-term risk, STE is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for STE.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
STE vs SI Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, SI has a market cap of 398.8M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while SI trades at $19.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas SI's P/E ratio is -10.04. In terms of profitability, STE's ROE is +0.11%, compared to SI's ROE of -0.24%. Regarding short-term risk, STE is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for STE.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
STE vs MOBI Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, MOBI has a market cap of 388.3M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while MOBI trades at $11.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas MOBI's P/E ratio is -0.62. In terms of profitability, STE's ROE is +0.11%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, STE is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for STE.Check MOBI's competition here
Edap Tms S.a. (NASDAQ: EDAP)
STE vs EDAP Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas EDAP's P/E ratio is -5.80. In terms of profitability, STE's ROE is +0.11%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, STE is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for STE.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
STE vs NYXH Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, NYXH has a market cap of 158.1M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while NYXH trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas NYXH's P/E ratio is -0.63. In terms of profitability, STE's ROE is +0.11%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, STE is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for STE.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
STE vs APYX Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, APYX has a market cap of 128M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while APYX trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas APYX's P/E ratio is -13.82. In terms of profitability, STE's ROE is +0.11%, compared to APYX's ROE of -0.79%. Regarding short-term risk, STE is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for STE.Check APYX's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
STE vs MDAI Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, MDAI has a market cap of 55.1M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while MDAI trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas MDAI's P/E ratio is -3.84. In terms of profitability, STE's ROE is +0.11%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, STE is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for STE.Check MDAI's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
STE vs WOK Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while WOK trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas WOK's P/E ratio is N/A. In terms of profitability, STE's ROE is +0.11%, compared to WOK's ROE of -0.07%. Regarding short-term risk, STE is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for STE.Check WOK's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
STE vs FEED Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, FEED has a market cap of 3.7M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while FEED trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas FEED's P/E ratio is -0.01. In terms of profitability, STE's ROE is +0.11%, compared to FEED's ROE of -0.44%. Regarding short-term risk, STE is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for STE.Check FEED's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
STE vs QTEXW Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, STE's ROE is +0.11%, compared to QTEXW's ROE of N/A. Regarding short-term risk, STE is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for STE.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
STE vs ITOC Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, ITOC has a market cap of 2.7M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while ITOC trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas ITOC's P/E ratio is -0.94. In terms of profitability, STE's ROE is +0.11%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, STE is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for STE.Check ITOC's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
STE vs BIAFW Comparison August 2026
STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, STE stands at 23B. In comparison, BIAFW has a market cap of 2.5M. Regarding current trading prices, STE is priced at $233.85 on the NYSE, while BIAFW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
STE currently has a P/E ratio of 22.65, whereas BIAFW's P/E ratio is 0.27. In terms of profitability, STE's ROE is +0.11%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, STE is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for STE.Check BIAFW's competition here